Sign in
CTY Stock Price, Chart, Stats & News
City Therapeutics, Inc. Common Stock
Save
City Therapeutics, Inc. Common Stock (CTY) does not currently pay a dividend.
202.51M
Market cap
–
Current P/E
–
Forward P/E
CTY chart
Fundamentals
Gross margin | 100.00% |
Operating margin | 97.78% |
Pretax margin | 96.06% |
Net margin | 95.83% |
Effective tax rate | 0.24% |
ROA | 13.85% |
ROE | 15.43% |
D/E | 0.06x |
Interest coverage ratio | 107.61x |
CTY valuation
P/E | – |
P/S | 7.43x |
P/B | 1.12x |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | 0.13x |
EV multiple | – |
About
City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference (RNAi) therapeutics. The company is based in Cambridge, MA. The company engineers potent, specific, and durable RNAi trigger molecules combined with precision targeting ligands to deliver siRNAs beyond the liver to tissues such as ocular and central nervous system targets.
Similar securities
Based on sector and market capitalization
Report issue